Skip to content
AnalystLens

ECOLAB INC. Quarterly Report for Q1 Ended Mar 31, 2023

Filing Date
Filed May 4, 2023
Period End
March 31, 2023
Security
ECL
One revenue dollarkept$0.07
In the record · 2016–202610-K1110-Q328-K144

ECL filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 144 current reports (8-K) between 2016 and 2026.

  1. Restructuring8-K · Jul ’18Jul ’18
  2. Deal closed8-K · Jun ’20Jun ’20
  3. Leadership change8-K · Feb ’22Feb ’22
  4. Leadership change8-K · May ’26May ’26

Summary

Summary of the 10-Q filed May 4, 2023. Cited figures are marked; the original filing is the authoritative source.

Ecolab Inc. reported strong first-quarter 2023 results, demonstrating resilience and growth in a dynamic economic environment.

Net sales increased by 9% year-over-year to $3.57 billiona, driven by a 13% increase in organic sales, indicating robust underlying business performance. This growth was primarily fueled by effective pricing strategies across all segments, which more than offset increased delivered product costs. The company's operating income saw a significant increase of 38% to $351.6 million, reflecting improved operational efficiencies and strong sales execution.

The company's diversified business segments, including Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences, all contributed positively to the top-line growth, with particular strength noted in water treatment, food & beverage, and life sciences. Despite inflationary pressures and foreign currency headwinds, Ecolab maintained a disciplined approach to cost management and strategic investments, leading to a notable improvement in profitability. The company's balance sheet remains solid, with sufficient liquidity to support ongoing operations and strategic initiatives.

Key Highlights

  1. Net sales increased by 9% to $3.57 billion in Q1 2023, with organic sales growing by 13%.
  2. Operating income surged by 38% to $351.6 million, indicating strong profitability improvement.
  3. All key segments (Global Industrial, Global Institutional & Specialty, Global Healthcare & Life Sciences) showed organic sales growth, demonstrating broad-based demand.
  4. Gross margin improved to 38.3% from 36.5% in the prior year period, driven by effective pricing strategies.
  5. The company maintained disciplined cost management, with SG&A as a percentage of sales decreasing slightly year-over-year.
  6. Ecolab generated strong operating cash flow of $198.2 million, supporting investments and shareholder returns.
  7. The company continues to manage its debt effectively, with a net debt to EBITDA ratio of 3.1 as of March 31, 2023.

Follow one dollar

Of each $1.00 of revenue in Q1 FY2023, Ecolab Inc. kept $0.07.

  1. Revenue$3.57B100.0%
  2. Cost of revenue−$2.21B61.7%
  3. Gross profit$1.37B38.3%
  4. Operating costs−$1.01B28.4%
  5. Operating income$351.6M9.8%
  6. Interest, other & tax−$118.2M3.3%
  7. Net income$233.4M6.5%
Computed from 10-QQ1 FY2023filed May 4, 2023Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Financial Statements

Q1 FY2023 against Q1 FY2022

Line itemQ1 FY2023Q1 FY2022Change
Revenue$3.57B$3.27B+9.3%
Cost of Revenue$2.21B$2.07B+6.4%
Gross Profit$1.37B$1.19B+14.5%
SG&A Expenses$990.30M$914.70M+8.3%
Operating Income$351.60M$254.50M+38.2%
Interest Expense$80.10M$55.10M+45.4%
Net Income$233.40M$171.90M+35.8%
EPS (Basic)$0.82$0.60+36.7%
EPS (Diluted)$0.82$0.60+36.7%
Shares Outstanding (Basic)284.60M286.20M−0.6%
Shares Outstanding (Diluted)285.90M288.10M−0.8%

Frequently Asked Questions

  1. What is Ecolab's outlook for the remainder of 2023 given the current economic climate?

    Ecolab anticipates a challenging macroeconomic environment, particularly in Europe, due to ongoing inflationary pressures and geopolitical instability. However, the company expects continued growth driven by its diversified segments and effective pricing strategies. Management is focused on navigating these challenges while continuing to invest in the business and return capital to shareholders.

  2. How did Ecolab manage rising costs and supply chain issues in the first quarter?

    Ecolab effectively managed rising delivered product costs and supply chain challenges through strong pricing initiatives across all segments. These pricing actions more than offset the increased costs, leading to an improvement in gross margin. The company also focused on operational efficiencies and productivity gains.

  3. What is the impact of foreign currency fluctuations on Ecolab's financial results?

    Foreign currency had an unfavorable impact on reported sales and operating income. The company strategically uses hedging instruments to mitigate some of this risk. Management evaluates performance on a fixed currency basis to better understand underlying operational trends, which showed stronger growth than reported results.

  4. Are there any significant restructuring charges impacting profitability?

    Ecolab recorded $27.7 million in total special charges in the first quarter of 2023, a decrease from $77.0 million in the prior year period. These charges are primarily related to restructuring activities, integration costs, and geopolitical events. The company has an ongoing 'Combined Program' expected to incur significant charges but aims to deliver substantial cost savings.